Idarubicin

This classification denotes an anthracycline antibiotic with the molecular formula C26H27NO9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZRP63D75JW, chemically known as 5,12-naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7s-cis)- but generally known as idarubicin, which bears US NIH Compound Identifier 42890. European Medicines Agency schedules Idarubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08111MIG. The term IDARUBICIN is an International Non-Proprietary Name. World Health Organization schedules idarubicin in its Anatomical Therapeutic Chemical (ATC) Classification. IDARUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idarubicin under HS 29419000 and SITC 54139. As of Q4 2014, IDARUBICIN remains the US FDA Preferred Term for this commodity. Idarubicin bears US NLM identifiers UMLS ID C0020789 and NCI Concept Code C562. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)CCCC2)C(=O)C)C1OC(C(O)C(N)C1)C.